{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:08Z","timestamp":1792787828086,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangzhou Science and Technology Program","award":["201604020037"],"award-info":[{"award-number":["201604020037"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670656"],"award-info":[{"award-number":["81670656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8187032497"],"award-info":[{"award-number":["8187032497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700620"],"award-info":[{"award-number":["81700620"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recommended regular saline flushing presents clinical ineffectiveness for hemodialysis (HD) patients at high risk of bleeding with heparin contraindication. Regional citrate anticoagulation (RCA) has previously been used with a Ca\n                      <jats:sup>2+<\/jats:sup>\n                      containing dialysate with prefiltered citrate in one arm (RCA-one). However, anticoagulation is not always achievable and up to 40% results in serious clotting in the venous expansion chamber. In this study, we have transferred one-quarter of the TSC from the prefiltered to the post filter based on RCA-one, which we have called RCA-two. The objective of this study was to compare the efficacy and safety of RCA-two with either saline flushing or RCA-one in HD patients with a high bleeding risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this investigator-initiated, multicenter, controlled, prospective, randomized clinical trial, 52 HD patients (77 sessions) were randomized to the RCA-2 and RCA-one group in part one of the trial, and 45 patients (64 sessions) were randomized to the RCA-2 and saline group in part two of the trial. Serious clotting events, adverse events and blood analyses were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:bold>S<\/jats:bold>\n                      erious clotting events in the RCA-two group were significantly lower compared with the RCA-one and saline group (7.89% vs. 30.77%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011; 3.03% vs. 54.84%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). The median circuit survival time was 240\u2009min (IQR 240 to 240) in the RCA-two group, was significantly longer than 230\u2009min (IQR 155 to 240,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) in the RCA-one group and 210\u2009min (IQR 135 to 240,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) in the saline group. The majority of the AEs were hypotension, hypoglycemia and chest tightness, most of which were mild in intensity. Eight patients (20.51%) in the RCA-one group, 4 patients (12.90%) in the saline group and 10 patients (26.31%) in the RCA-two group,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data demonstrated that the modified anticoagulation protocol was more effective and feasible during hemodialysis therapy for patients at high risk of bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      GDREC,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03419923?term=GDREC2017250H&amp;rank=1\">GDREC2017250H<\/jats:ext-link>\n                      . Registered February 2, 2018; retrospectively registered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-019-1661-y","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T13:03:25Z","timestamp":1576760605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies"],"prefix":"10.1186","volume":"20","author":[{"given":"Ting","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuifu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaban","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"1661_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"key":"1661_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ki.2012.346","volume":"83","author":"JE Flythe","year":"2013","unstructured":"Flythe JE, Curhan GC, Brunelli SM. Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int. 2013;83:104\u201313.","journal-title":"Kidney Int"},{"key":"1661_CR3","first-page":"c179","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO Clinical practice guidelines for acute kidney disease. Kidney Int. 2012;120:c179\u201384.","journal-title":"Kidney Int"},{"key":"1661_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00134-003-1672-8","volume":"29","author":"S Uchino","year":"2003","unstructured":"Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit \u201cdown-time\u201d on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med. 2003;29:575\u20138.","journal-title":"Intensive Care Med"},{"key":"1661_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1056\/NEJM198302033080506","volume":"308","author":"RV Pinnick","year":"1983","unstructured":"Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983;308:258\u201361.","journal-title":"N Engl J Med"},{"key":"1661_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","volume":"30","author":"M Monchi","year":"2004","unstructured":"Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004;30:260\u20135.","journal-title":"Intensive Care Med"},{"key":"1661_CR7","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","volume":"67","author":"DJ Kutsogiannis","year":"2005","unstructured":"Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005;67:2361\u20137.","journal-title":"Kidney Int"},{"key":"1661_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"SH Oudemans-van","year":"2009","unstructured":"Oudemans-van SH, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37:545\u201352.","journal-title":"Crit Care Med"},{"key":"1661_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1053\/j.ajkd.2007.02.001","volume":"49","author":"P Evenepoel","year":"2007","unstructured":"Evenepoel P, Dejagere T, Verhamme P, et al. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Am J Kidney Dis. 2007;49:642\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1661_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1525-1594.2007.00459.x","volume":"32","author":"J Buturovic","year":"2008","unstructured":"Buturovic J, Gubensek J, Cerne D, Ponikvar R. Standard citrate versus sequential citrate\/anticoagulant-free anticoagulation during hemodialysis: a randomized trial. Artif Organs. 2008;32:77\u201381.","journal-title":"Artif Organs"},{"key":"1661_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/039139880803100507","volume":"31","author":"J Buturovic-Ponikvar","year":"2008","unstructured":"Buturovic-Ponikvar J, Cerne S, Gubensek J, Ponikvar R. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial. Int J Artif Organs. 2008;31:418\u201324.","journal-title":"Int J Artif Organs"},{"key":"1661_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000182111","volume":"28","author":"RD Swartz","year":"1981","unstructured":"Swartz RD. Hemorrhage during high-risk hemodialysis using controlled heparinization. Nephron. 1981;28:65\u20139.","journal-title":"Nephron"},{"key":"1661_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10047-018-1062-1","volume":"21","author":"A Kortge","year":"2018","unstructured":"Kortge A, Wild T, Heskamp B, et al. Thrombogenicity and long-term cytokine removal capability of a novel asymmetric triacetate membrane hemofilter. J Artif Organs. 2018;21:435\u201342.","journal-title":"J Artif Organs"},{"key":"1661_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1525-1594.2010.01038.x","volume":"35","author":"P Richtrova","year":"2011","unstructured":"Richtrova P, Rulcova K, Mares J, Reischig T. Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect. Artif Organs. 2011;35:83\u20138.","journal-title":"Artif Organs"},{"key":"1661_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/IJNRD.S43252","volume":"6","author":"E Zimbudzi","year":"2013","unstructured":"Zimbudzi E. Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended? Int J Nephrol Renovasc Dis. 2013;6:65\u20139.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"1661_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jama.2015.19394","volume":"315","author":"MA Detry","year":"2016","unstructured":"Detry MA, Ma Y. Analyzing repeated measurements using mixed models. JAMA. 2016;315:407\u20138.","journal-title":"JAMA"},{"key":"1661_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","volume":"19","author":"D Kaw","year":"2006","unstructured":"Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006;19:317\u201322.","journal-title":"Semin Dial"},{"key":"1661_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.thromres.2005.03.029","volume":"118","author":"AS Gangji","year":"2006","unstructured":"Gangji AS, Sohal AS, Treleaven D, Crowther MA. Bleeding in patients with renal insufficiency: a practical guide to clinical management. Thromb Res. 2006;118:423\u20138.","journal-title":"Thromb Res"},{"key":"1661_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ki.2013.170","volume":"84","author":"MM Sood","year":"2013","unstructured":"Sood MM, Larkina M, Thumma JR, et al. Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS. Kidney Int. 2013;84:600\u20138.","journal-title":"Kidney Int"},{"key":"1661_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ndt\/gfy031","volume":"34","author":"J Feldberg","year":"2018","unstructured":"Feldberg J, Patel P, Farrell A, et al. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. Nephrol Dial Transplant. 2018;34:265\u201377.","journal-title":"Nephrol Dial Transplant"},{"key":"1661_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1523-1755.2004.00473.x","volume":"65","author":"A Ishani","year":"2004","unstructured":"Ishani A, Herzog CA, Collins AJ, Foley RN. Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int. 2004;65:1017\u201325.","journal-title":"Kidney Int"},{"key":"1661_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.ajkd.2007.06.017","volume":"50","author":"MJ Elliott","year":"2007","unstructured":"Elliott MJ, Zimmerman D, Holden RM. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis. 2007;50:433\u201340.","journal-title":"Am J Kidney Dis"},{"key":"1661_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2215\/CJN.01810407","volume":"3","author":"RM Holden","year":"2008","unstructured":"Holden RM, Harman GJ, Wang M, Holland D, Day AG. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:105\u201310.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1661_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1525-139X.2011.00856.x","volume":"24","author":"D Trainor","year":"2011","unstructured":"Trainor D, Borthwick E, Ferguson A. Perioperative management of the hemodialysis patient. Semin Dial. 2011;24:314\u201326.","journal-title":"Semin Dial"},{"key":"1661_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/ajkd.2002.30551","volume":"39","author":"P Evenepoel","year":"2002","unstructured":"Evenepoel P, Maes B, Vanwalleghem J, et al. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis. 2002;39:315\u201323.","journal-title":"Am J Kidney Dis"},{"key":"1661_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000490409","volume":"46","author":"D Mahmood","year":"2018","unstructured":"Mahmood D, Stegmayr BG. Haemodialysis with Tinzaparin versus dialysate citrate as anticoagulation. Blood Purif. 2018;46:257\u201363.","journal-title":"Blood Purif"},{"key":"1661_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/039139880803100408","volume":"31","author":"J Buturovic-Ponikvar","year":"2008","unstructured":"Buturovic-Ponikvar J, Gubensek J, Ponikvar R. Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap. Int J Artif Organs. 2008;31:323\u20138.","journal-title":"Int J Artif Organs"},{"key":"1661_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2215\/CJN.09460912","volume":"8","author":"JE Flythe","year":"2013","unstructured":"Flythe JE, Curhan GC, Brunelli SM. Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol. 2013;8:1151\u201361.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1661_CR29","first-page":"188","volume":"125","author":"V Kovacic","year":"2003","unstructured":"Kovacic V. Kt\/V as a measure of hemodialysis adequacy. Lijec Vjesn. 2003;125:188\u201391.","journal-title":"Lijec Vjesn"},{"key":"1661_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.transci.2014.03.002","volume":"50","author":"Z Bicakci","year":"2014","unstructured":"Bicakci Z, Olcay L. Citrate metabolism and its complications in non-massive blood transfusions: association with decompensated metabolic alkalosis respiratory acidosis and serum electrolyte levels. Transfus Apher Sci. 2014;50:418\u201326.","journal-title":"Transfus Apher Sci"},{"issue":"Suppl 1","key":"1661_CR31","first-page":"173","volume":"34","author":"A Kvesic","year":"2010","unstructured":"Kvesic A, Soljic M, Galic G, et al. The relation between the serum calcium level and the complication incidence in haemodialysis uremic patients. Coll Antropol. 2010;34(Suppl 1):173\u201380.","journal-title":"Coll Antropol"},{"key":"1661_CR32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1681\/ASN.2008080824","volume":"20","author":"KE Chan","year":"2009","unstructured":"Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol. 2009;20:872\u201381.","journal-title":"J Am Soc Nephrol"},{"key":"1661_CR33","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ki.2009.477","volume":"77","author":"V Wizemann","year":"2010","unstructured":"Wizemann V, Tong L, Satayathum S, et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int. 2010;77:1098\u2013106.","journal-title":"Kidney Int"},{"key":"1661_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/00365519209088361","volume":"52","author":"G Hafner","year":"1992","unstructured":"Hafner G, Swars H, Ehrenthal W, et al. The control of anti-coagulation in acute dialyses with sensitive laboratory parameters. Scand J Clin Lab Invest. 1992;52:289\u201396.","journal-title":"Scand J Clin Lab Invest"},{"key":"1661_CR35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/hdi.12371","volume":"20","author":"J Gubensek","year":"2016","unstructured":"Gubensek J, Lolic M, Ponikvar R, Buturovic-Ponikvar J. D-dimer levels in maintenance hemodialysis patients: high prevalence of positive values also in the group without predisposing diseases. Hemodial Int. 2016;20:198\u2013203.","journal-title":"Hemodial Int"},{"key":"1661_CR36","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/elps.11501601195","volume":"16","author":"MK Robinson","year":"1995","unstructured":"Robinson MK, Myrick JE, Henderson LO, et al. Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome. Electrophoresis. 1995;16:1176\u201383.","journal-title":"Electrophoresis"},{"key":"1661_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.2044-8317.2012.02042.x","volume":"66","author":"DM Rom","year":"2013","unstructured":"Rom DM. An improved Hochberg procedure for multiple tests of significance. Br J Math Stat Psychol. 2013;66:189\u201396.","journal-title":"Br J Math Stat Psychol"},{"key":"1661_CR38","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1515\/CCLM.2006.164","volume":"44","author":"AJ Bakker","year":"2006","unstructured":"Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total\/ionised calcium. Clin Chem Lab Med. 2006;44:962\u20136.","journal-title":"Clin Chem Lab Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1661-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T18:51:18Z","timestamp":1722192678000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1661-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1661-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11875\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11875\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11875\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"30 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval of the study protocol was obtained from the institutional review boards of each participating hospital, including Guangdong Provincial People\u2019s Hospital (Project Number: 2017250H (R1)), the First Affiliated Hospital of Guangzhou University of Chinese Medicine (Project Number: ZYYECK [2018]008), the Second Affiliated Hospital of Guangzhou Medicine University (Project Number: 2018-hs-06), and Guangzhou Hospital of Chinese Medicine (Project Number: B2017\u2013189-01). Written informed consent was obtained from the patients or their legal representatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}